PA
PTLA

Perennial Advisors’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Perennial Advisors’s Portfolio PTLA Stock Details PTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-400
Closed -$8K – 205
2018
Q4 		$8K Hold
400
– – 0.01% 173
2018
Q3 		$11K Hold
400
– – 0.01% 165
2018
Q2 		$15K Hold
400
– – 0.01% 154
2018
Q1 		$13K Hold
400
– – 0.01% 159
2017
Q4 		$19K Hold
400
– – 0.01% 147
2017
Q3 		$22K Sell
400
-50
-11% -$2.94K 0.01% 129
2017
Q2 		$25K Hold
450
– – 0.02% 125
2017
Q1 		$18K Hold
450
– – 0.01% 130
2016
Q4 		$10K Buy
+450
New +$8.79K 0.01% 165

Other funds holding PTLA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Perennial Advisors's PTLA Position: Q1 2019 in Review

Perennial Advisors sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q1 2019, closing a stake of 400 shares — an estimated $8K sold.

Perennial Advisors first reported a position in PTLA in Q4 2016 and held it in 9 quarters. The position peaked at $25K in Q2 2017. 209 funds tracked by Wall St. Rank hold PTLA as of Q1 2019.

  • Perennial Advisors reported no remaining Portola Pharmaceuticals, Inc. position as of Q1 2019 after selling out during the quarter.
  • Perennial Advisors sold 400 Portola Pharmaceuticals, Inc. shares in Q1 2019, an estimated $8K.
  • Perennial Advisors first reported a position in Portola Pharmaceuticals, Inc. in Q4 2016 and held it in 9 quarters.
  • Perennial Advisors's Portola Pharmaceuticals, Inc. position peaked at $25K in Q2 2017.
  • 209 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q1 2019.

Based on Perennial Advisors's 13F filing for Q1 2019, filed 30 Apr 2019.